Illumina (BSP:I1LM34) Inventories, Finished Goods : R$174 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Illumina Inventories, Finished Goods?

Illumina's quarterly finished goods declined from Sep. 2023 (R$173 Mil) to Dec. 2023 (R$147 Mil) but then increased from Dec. 2023 (R$147 Mil) to Mar. 2024 (R$174 Mil).

Illumina's annual finished goods declined from Dec. 2021 (R$181 Mil) to Dec. 2022 (R$147 Mil) but then increased from Dec. 2022 (R$147 Mil) to Dec. 2023 (R$147 Mil).

Illumina Inventories, Finished Goods Historical Data

The historical data trend for Illumina's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina Inventories, Finished Goods Chart

Illumina Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

106.72

113.18

180.96

146.87

146.99

Illumina Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Finished Goods	Get a 7-Day Free Trial															140.63	140.76	172.86	146.99	174.29

Illumina Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Illumina (BSP:I1LM34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (BSP:I1LM34) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

ILMN:USA ILMN:Mexico 1ILMN:Italy ILU:Germany ILU:Germany ILU:Germany ILMN:Austria

Address

5200 Illumina Way, San Diego, CA, USA, 92122

Website

https://www.illumina.com

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates about 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (about 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Illumina (BSP:I1LM34) Headlines

No Headlines